A comprehensive view of Stallergenes Greer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Aptar Digital Health develops iPUMP, a connected allergy assistant launched by Stallergenes Greer in France aimed at solving treatment adherence issues; pump features a pressure sensor and integrated timer to better manage Aalergen immunotherapy treatment
Published: October 24, 2023 by AptarGroup Inc.
Nestlé sells its peanut allergy treatment business, Palforzia, to biopharmaceutical firm Stallergenes Greer to focus on core strengths and key growth sectors;
Published: September 05, 2023 by GlobeNewswire Europe
Nestle continues strategic review of peanut allergy drug Palforzia due to slower than expected adoption by patients and healthcare professionals; potential sale of the medicine to Stallergenes Greer under consideration
Published: July 27, 2023 by SeeNews Deals
Nestle reportedly in talks to sell peanut allergy remedy Palforzia to biopharmaceutical company Stallergenes Greer reports Bloomberg; Nestle reports slower than expected adoption of the product
Published: July 14, 2023 by just-food

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count